HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GCH1 expression in human cerebellum from healthy individuals is not gender dependent.

Abstract
Dopa-responsive dystonia (DRD) is a familial childhood-onset disease characterized by fluctuating dystonia, associated with tremor and parkinsonism in some patients. In most families the disease displays autosomal dominant inheritance due to mutations in the GTP cyclohydrolase 1 gene (GCH1). Penetrance and symptom severity display strong female predominance for which gender-specific GCH1 expression has been hypothesized. In this study, GCH1 mRNA expression was measured in cerebellar tissue from 66 healthy human subjects (30 women), and in cerebellar and nigral tissue from eight individuals. No significant difference was found between men and women with small effect sizes observed. Although the correlation between cerebellar and nigral GCH1 expression remains to be further examined, this exploratory study does not support gender-specific GCH1 expression being the basis for the skewed gender distribution observed in DRD patients.
AuthorsChristian Wider, Sarah Lincoln, Justus C Dachsel, Gregory Kapatos, Michael G Heckman, Nancy N Diehl, Spiridon Papapetropoulos, Deborah Mash, Alex Rajput, Ali H Rajput, Dennis W Dickson, Zbigniew K Wszolek, Matthew J Farrer
JournalNeuroscience letters (Neurosci Lett) Vol. 462 Issue 1 Pg. 73-5 (Oct 02 2009) ISSN: 1872-7972 [Electronic] Ireland
PMID19573577 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Messenger
  • GTP Cyclohydrolase
Topics
  • Aged
  • Aged, 80 and over
  • Aging
  • Cerebellum (enzymology)
  • Dystonic Disorders
  • Female
  • GTP Cyclohydrolase (metabolism)
  • Humans
  • Linear Models
  • Male
  • Middle Aged
  • RNA, Messenger (metabolism)
  • Sex Characteristics
  • Substantia Nigra (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: